Healthcare Utilization and Costs after Receiving a Positive <i>BRCA1/2</i> Result from a Genomic Screening Program

Healthcare Utilization and Costs after Receiving a Positive <i>BRCA1/2</i> Result from a Genomic Screening Program

Population genomic screening has been demonstrated to detect at-risk individuals who would not be clinically identified otherwise. However, there are concerns about the increased utilization of unnecessary services and the associated increase in costs. The objectives of this study are twofold: (1) d...

Full description

Bibliographic Details
Main Authors: Jing Hao, Dina Hassen, Kandamurugu Manickam, Michael F. Murray, Dustin N. Hartzel, Yirui Hu, Kunpeng Liu, Alanna Kulchak Rahm, Marc S. Williams, Amanda Lazzeri, Adam Buchanan, Amy Sturm, Susan R. Snyder
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Journal of Personalized Medicine
Subjects:
genomic screening
<i>brca1/2</i>
healthcare utilization
healthcare costs
uptake of risk management
Online Access:https://www.mdpi.com/2075-4426/10/1/7

Internet

https://www.mdpi.com/2075-4426/10/1/7

Similar Items